International Update: Global Covid-19 cases pass 13 million – cities and states returning to tighter restrictions worldwide
14 July Global: More than 13 million people around the world have now been confirmed to have had the coronavirus,…
Latest Uncategorised
-
8 months
-
9 months
-
9 months
-
9 months
-
8 months
-
9 months
-
9 months
-
9 months
Clinical trial disruption due to Covid-19 has begun to slow
Since early March, many companies have delayed the initiation of or completely withdrawn planned clinical trials, as well as suspending…
Latest News
View More
Leidos to conduct clinical trials for Covid-19 therapeutics
The Defense Threat Reduction Agency (DTRA) in the US has awarded a new project agreement to Leidos to conduct clinical trials for Covid-19 therapeutics. The…
Pfizer and BioNTech to test Covid-19 vaccine against new variants
Pfizer and BioNTech have initiated a new trial to determine the efficacy of the third dose of their Covid-19 vaccine (BNT162b2) against emerging SARS-CoV-2 variants.…
GSK to amend Covid-19 study to confirm efficacy in older patients
GlaxoSmithKline (GSK) has decided to amend a Covid-19 study that seeks to determine the effectiveness of a fully human monoclonal…
Roche reports positive data from SMA treatment trial
Roche has reported positive data from the dose finding Part I FIREFISH study of Evrysdi (risdiplam) in infants with symptomatic…
Solano Hematology selects VIPER for clinical trial recruitment
Solano Hematology Oncology has adopted Deep Lens’ artificial intelligence-based platform VIPER to improve patient access to clinical oncology trials. The…
Constant Therapeutics’ drug enters Phase II trial for Covid-19 in Israel
Israel’s Rambam Medical Health Care Campus and Ziv Medical Center researchers have begun a Phase II clinical trial of Constant…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View MoreUKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The Complete Guide to Freelancers in MedTech
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…